Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health

Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health

Abstract EFSA asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to update the guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health published in 2011. The update takes into accounts experiences gained with eval...

Full description

Bibliographic Details
Main Authors:	EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), Dominique Turck, Jean‐Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather‐Tait, Marina Heinonen, Karen Ildico Hirsch‐Ernst, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Monika Neuhäuser‐Berthold, Grażyna Nowicka, Kristina Pentieva, Yolanda Sanz, Anders Sjödin, Martin Stern, Daniel Tomé, Henk Van Loveren, Marco Vinceti, Peter Willatts, Ambroise Martin, John Joseph Strain, Leng Heng, Silvia Valtueña Martínez, Alfonso Siani
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	EFSA Journal
Subjects:	health claims scientific requirements antioxidants oxidative damage cardiovascular health guidance
Online Access:	https://doi.org/10.2903/j.efsa.2018.5136

Similar Items

NWT‐02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk and reduction of the loss of vision: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), et al.
Published: (2018-01-01)

L‐carnitine and contribution to normal lipid metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), et al.
Published: (2018-01-01)

Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2)
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-01-01)

Vibigaba (germinated brown rice) and maintenance of normal blood cholesterol concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

Vibigaba (germinated brown rice) and maintenance of long‐term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

Sugar‐free hard confectionery with at least 90% erythritol and reduction of dental plaque which reduces the risk of dental caries: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

Vibigaba (germinated brown rice) and reduction of body weight in the context of an energy‐restricted diet: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

Vibigaba (germinated brown rice) and maintenance of normal blood pressure: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

Stablor® and reduction of visceral fat while maintaining lean mass: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-02-01)

Carbohydrate solutions and contribute to the improvement of physical performance during a high‐intensity and long‐lasting physical exercise: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2018-03-01)

Xanthohumol in XERME®, a xanthohumol‐enriched roasted malt extract, and protection of DNA from oxidative damage: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2018-03-01)

Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2018-05-01)

Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Condensyl® and decreases sperm DNA damage which is a risk factor for male infertility: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

A fixed carbohydrate:protein ratio ≤ 1.8 on an energy basis consumed in the context of an energy‐restricted diet and reduction of body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-06-01)

Scientific Opinion on the energy conversion factor of d‐tagatose for labelling purposes
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2016-11-01)

Black tea and maintenance of normal endothelium‐dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA panel), et al.
Published: (2018-01-01)

Lactobacillus fermentum CECT 5716 and a reduction of the Staphylococcus load in breast milk which reduces the risk of infectious mastitis: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

‘Nutrimune®’ and immune defence against pathogens in the gastrointestinal and upper respiratory tracts: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-01-01)

Vitamin C and protection of DNA, proteins and lipids from oxidative damage: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-01-01)

Scientific Opinion related to a notification from DuPont Nutrition Biosciences Aps on behenic acid from mustard seeds to be used in the manufacturing of certain emulsifiers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 – for permanent exemption from labelling
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2016-11-01)

Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow‐on formula manufactured from protein hydrolysates (Revision 1) 1
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2021-03-01)

Scientific Opinion on the safety and suitability for use by infants of follow‐on formulae with a protein content of at least 1.6 g/100 kcal
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow‐on formula manufactured from protein hydrolysates
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Safety of Allanblackia seed oil for extended uses in vegetable oils and milk and in yellow fat and cream‐based spreads up to 30% (w/w)
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2018-08-01)

Safety of synthetic N‐acetyl‐d‐neuraminic acid as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)

Safety of proline‐specific oligopeptidase as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-02-01)

Scientific Opinion on taxifolin‐rich extract from Dahurian Larch (Larix gmelinii)
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-02-01)

Safety of hydroxytyrosol as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-03-01)

Safety of alginate‐konjac‐xanthan polysaccharide complex (PGX) as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Dietary reference values for vitamin K
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Safety of Ecklonia cava phlorotannins as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-10-01)

Safety of dried aerial parts of Hoodia parviflora as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-10-01)

Statement on the safety of EstroG‐100™ as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2018-05-01)

Safety of d‐ribose as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2018-05-01)

Safety of cranberry extract powder as a novel food ingredient pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-05-01)

Safety of synthetic l‐ergothioneine (Ergoneine®) as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2016-11-01)

Update of the tolerable upper intake level for vitamin D for infants
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), et al.
Published: (2018-08-01)

Safety of 1‐methylnicotinamide chloride (1‐MNA) as a novel food pursuant to Regulation (EC) No 258/97
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-10-01)

Cannot write session to /tmp/vufind_sessions/sess_dkbeovkclmsi39vg035574j98s